Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07218120 · ClinicalTrials.gov registry record · NA

In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy

A NA study of Healthy Subjects and Memory Decline, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT07218120: Recruiting NA study of Healthy Subjects and Memory Decline, sponsored by University of Southern California.

NCT07218120 is a NA study of Healthy Subjects and Memory Decline that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 400 participants, above the 123-participant average among 69 other Healthy Subjects trials with a reported enrollment target (225% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07218120, a NA study of Healthy Subjects and Memory Decline, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented in clinical research. This is true across a range of clinical areas but no more so than in Alzheimer's Disease Research. The purpose of this study is to assess whether offering small $25 financial incentives can increase enrollment of diverse community members to the Alzheimer's Prevention Trial (APT) Webstudy, a memory concerns registry meant to accelerate clinical trials, relative to non-monetary incentives such as a reusable grocery bag. To do this we will test in-person recruitment efforts at community events and locations, such as Northgate Gonzalez Market locations and local food bank events. We also aim to compare the relative cost of recruiting an additional person to the APT Webstudy.

Primary Outcome

Participant enrolled in the APT Webstudy, which includes completion of at least one of two remote cognitive assessments, on the recruitment day.

Interventions

  • OTHER Financial Incentive
  • OTHER Active Comparator #1

Study Locations (1)

California

  • Northgate Gonzalez Market - Chula Vista

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2025-06-09
Est. Completion 2025-12-31
Phase NA
University of Southern California

617 total trials

What NCT07218120 shows while recruiting

NCT07218120 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 123-participant average among 69 other Healthy Subjects trials with a reported enrollment target (225% higher).

The record links to 2 conditions, with Healthy Subjects appearing as the primary indexed condition, and to 2 interventions - of which Financial Incentive is the first listed.

NCT07218120 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07218120 about?

NCT07218120 is a clinical study titled "In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy". Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented in clinical research. This is true across a range of clinical areas but no more so than in Alzheimer's Disease Research...

What is the current status of trial NCT07218120?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-06-09. Estimated completion is 2025-12-31.

What conditions does trial NCT07218120 study?

This clinical trial studies the following conditions: Healthy Subjects, Memory Decline.

What interventions are being tested in trial NCT07218120?

The interventions under investigation include: Financial Incentive (OTHER), Active Comparator #1 (OTHER).

Who is sponsoring clinical trial NCT07218120?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07218120 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Subjects

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07218120's enrollment target sits among peer trials

400 4th of 69 higher than 66 of 69 other Healthy Subjects trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Subjects trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07218120, the US trial registry maintained by the National Library of Medicine. NCT07218120 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.